Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells

BACKGROUND: Flow cytometric immunophenotyping has been used to identify neoplastic plasma cell populations in patients with multiple myeloma (MM). Previous reports have described the use of several antigens, including CD38, CD138, CD56, CD117, CD52, CD19 and CD45, to distinguish distinct populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Tae-Dong, Park, Chan-Jeoung, Shim, Hyoeun, Jang, Seongsoo, Chi, Hyun-Sook, Yoon, Dok Hyun, Kim, Dae-Young, Lee, Jung-Hee, Lee, Je-Hwan, Suh, Cheolwon, Lee, Kyoo Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538797/
https://www.ncbi.nlm.nih.gov/pubmed/23320004
http://dx.doi.org/10.5045/kjh.2012.47.4.260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538797/
https://www.ncbi.nlm.nih.gov/pubmed/23320004
http://dx.doi.org/10.5045/kjh.2012.47.4.260

Ejemplares similares